Reich Samuel J 🟢 acquired 4.8M shares (1 derivative) of SAB Biotherapeutics, Inc. (SABS) at $2.17 ($10.4M) Transaction Date: Aug 26, 2025 | Filing ID: 112077
New Form 8-K - COGNITION THERAPEUTICS INC Filed: 2025-08-28 AccNo: 0001104659-25-084845 Size: 646 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
New Form 8-K - HERON THERAPEUTICS, INC. /DE/ Filed: 2025-08-28 AccNo: 0000950170-25-112048 Size: 198 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Director Tierney David S 🟡 adjusted position in 26.0K shares (1 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) at $20.20 Transaction Date: Aug 27, 2025 | Filing ID: 000302
Kropotova Alexandra 🟢 acquired 2.4M shares (1 derivative) of SAB Biotherapeutics, Inc. (SABS) at $2.17 ($5.2M) Transaction Date: Aug 26, 2025 | Filing ID: 112047
Russell Alan J 🟡 adjusted position in 100.0K shares (1 derivative) of Edgewise Therapeutics, Inc. (EWTX) at $14.60 ($1.5M) Transaction Date: Aug 26, 2025 | Filing ID: 000003